楚江新材(002171.SZ):天鳥高新擬5000萬元設立子公司
格隆匯12月4日丨楚江新材(002171.SZ)公佈,公司控股子公司天鳥高新擬以自有資金出資人民幣5000萬元對外投資設立“蕪湖天鳥高新技術有限公司”(暫定名,具體以工商行政管理部門核准登記為準),佔註冊資本的100%。
天鳥高新在蕪湖設立子公司,核心是為了充分發揮其在碳纖維預製件領域積累的產品優勢、技術優勢和人才優勢,有利於推動碳碳複合材料全產業鏈的形成,對公司在軍工新材料全面佈局具有戰略意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.